Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Context Therapeutics Inc. - Common Stock
(NQ:
CNTX
)
2.196
-0.084 (-3.71%)
Streaming Delayed Price
Updated: 11:15 AM EST, Feb 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
376,827
Open
2.260
Bid (Size)
2.190 (300)
Ask (Size)
2.200 (1,200)
Prev. Close
2.280
Today's Range
2.160 - 2.300
52wk Range
0.4900 - 2.850
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Context Therapeutics to Participate in Upcoming Investor Conferences
Today 7:30 EST
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026
From
Context Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+41.6%
+41.6%
1 Month
+36.4%
+36.4%
3 Month
+83.0%
+83.0%
6 Month
+224.2%
+224.2%
1 Year
+162.3%
+162.3%
More News
Read More
Wondering what's happening in today's after-hours session?
↗
January 05, 2026
Via
Chartmill
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 Upside – DVLT, UFG, VRME, ARBE More Inside
January 05, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
From
Equity Insider
Via
GlobeNewswire
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
November 07, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
November 05, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics to Participate in Upcoming Investor Conferences
October 28, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
October 06, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
October 02, 2025
Via
Benzinga
Context Therapeutics to Participate in Upcoming Investor Conferences
August 27, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
CONTEXT THERAPEUTICS INC (NASDAQ:CNTX) Posts Wider Q2 2025 Loss Amid Continued Pipeline Progress
↗
August 06, 2025
Via
Chartmill
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
August 06, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 05, 2025
Via
Benzinga
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
June 02, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer
May 29, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
May 07, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Announces Chief Medical Officer Transition
May 05, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Presents Preclinical and Translational Data for CT-95, a Mesothelin Targeting T Cell Engager, at 2025 AACR Annual Meeting
April 30, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95
April 09, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Unusual volume stocks in Friday's session
↗
April 04, 2025
Via
Chartmill
These stocks that are showing activity before the opening bell on Thursday.
↗
April 03, 2025
Via
Chartmill
Context Therapeutics to Participate in Upcoming Investor Conferences
April 01, 2025
From
Context Therapeutics Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Context Therapeutics Inc. - Common Stock publicly traded?
Yes, Context Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Context Therapeutics Inc. - Common Stock trade on?
Context Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Context Therapeutics Inc. - Common Stock?
The ticker symbol for Context Therapeutics Inc. - Common Stock is CNTX on the Nasdaq Stock Market
What is the current price of Context Therapeutics Inc. - Common Stock?
The current price of Context Therapeutics Inc. - Common Stock is 2.196
When was Context Therapeutics Inc. - Common Stock last traded?
The last trade of Context Therapeutics Inc. - Common Stock was at 02/09/26 11:15 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
